Patients | 302 | 61 (17) | 41 (11) | 20 (6) |
Type of DSA | | | | |
HLA type I | | 7 (11) | 3 (7) | 4 (20) |
HLA type I+type II | | 2 (3) | 1 (2) | 1 (5) |
HLA type II (DQ) | | 31 (51) | 24 (59) | 9 (45) |
HLA type II (DR) | | 12 (20) | 7 (17) | 5 (25) |
HLA type II (DQ+DR) | | 7 (11) | 6 (15) | 1 (5) |
Time to DSAs days | | 370 (44–765) | 530 (131–761) | 62 (22–1280) |
CLAD incidence | 57 (19) | 27 (44) | 19 (46) | 8 (40) |
BOS | 49 (16) | 17 (28) | 11 (27) | 6 (30) |
rCLAD | 8 (3) | 10 (16) | 8 (20) | 2 (10) |
Ever acute rejection | 92 (30) | 24 (39) | 19 (46) | 5 (25) |
Ever acute rejection grade ≥2 | 42 (14) | 12 (20) | 11 (24) | 1 (5) |
Ever lymphocytic bronchiolitis | 120 (40) | 24 (39) | 18 (44) | 6 (30) |
Ever lymphocytic bronchiolitis grade ≥2 | 47 (16) | 13 (21) | 10 (24) | 3 (15) |